Related Experiment Videos
Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition
R Petric1, D Freeman, C Wallace
1Department of Pharmacology, University Hospital, University of Western Ontario, London, Canada.
Transplantation
|December 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adolescents and young adults with cancers: comparative analyses of incidence and survival between Europe and the United States.
ESMO real world data and digital oncology·2026
Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries.
European journal of cancer (Oxford, England : 1990)·2025
Geographical variability in survival of European children with central nervous system tumours.
European journal of cancer (Oxford, England : 1990)·2017
Observation of two new Ξ(b)(-) baryon resonances.
Physical review letters·2015
Precision measurement of CP violation in B(S)(0)→J/ΨK+K- decays.
Physical review letters·2015
Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers.
Transplantation·2026
A Systematic Intracranial Exposure-Response Evaluation of Brain-Penetrant Inhibitors: Informing Dose Selection for Brain Metastases.
Clinical and translational science·2026
Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
Journal of cardiovascular pharmacology·2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Analytical methods : advancing methods and applications·2026
Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment.
Chemical communications (Cambridge, England)·2026
Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics.
Drug development and industrial pharmacy·2026